|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
59.000 -0.600 (-1.007%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -- RMB (cts) | |
| Net Profit | -301.22 RMB (MIL) | DPS | -- RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -216.10 | -118.50 | 0 | -- | -176.00 | -256.20 |
| 2026 | -369.10 | -186.00 | 0 | -- | -323.30 | -414.90 |
| 2027 | 78.30 | 39.50 | 0 | -- | 475.30 | -318.70 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -176.00 | -88.00 | -- | CMB INT'L SEC | Buy | 80.27 | 03/09/2025 | |
| 2025 | -256.20 | -149.00 | -- | MORGAN STANLEY | Equal-weight | 59.00 | 16/10/2025 | |
| 2026 | -414.90 | -209.00 | -- | CMB INT'L SEC | -- | -- | 03/09/2025 | |
| 2026 | -323.30 | -163.00 | -- | MORGAN STANLEY | -- | -- | 16/10/2025 | |
| 2027 | -318.70 | -160.00 | -- | CMB INT'L SEC | -- | -- | 03/09/2025 | |
| 2027 | 475.30 | 239.00 | -- | MORGAN STANLEY | -- | -- | 16/10/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/10/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |